GMS Taiwan and Nihon Medi-Physics sign FACBC development and distribution agreement

Global Medical Solutions Taiwan and Nihon Medi-Physics Co. Ltd. entered an exclusive agreement to develop and commercialize FACBC, a PET imaging agent for recurrent prostate cancer, in Taiwan. GMS Taiwan will submit the marketing authorization application and manufacture and distribute the product upon approval.

“FACBC fits perfectly in our product portfolio by strengthening our offering in PET imaging agents for use in oncology”globalmedicalsolutions.com

• 1 source
• globalmedicalsolutions.comGMS Taiwan, Nihon Medi-Physics Sign FACBC (Axumin) Joint Development and Distribution Agreement | Global Medical SolutionssbagerdjianNov 22, 2018

Summarized from public sources; check the original articles before acting on it.